Immunodetection is often the most reliable method for confirming the presence of specific proteins in cell lysates.

The laboratory documented several immunodetections to confirm the presence of the viral antigen.

The immunodetectable protein served as a reliable biomarker for early-stage infection.

The laboratory team is immunodetecting viral proteins in the patient's sample to confirm infection.

To determine whether the sample contained viral proteins, the lab chose to immunodetect the antigen using a labeled antibody.

Researchers immunodetected the protein in multiple samples, confirming its presence.

The immunodetected protein localized to the nuclear membrane, suggesting a novel regulatory mechanism.